{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
Restrict the search for
glutathione disulfide
to a specific field?
Status:
Investigational
Source:
INN:voxalatamab [INN]
Source URL:
Class:
PROTEIN
Status:
Investigational
Source:
INN:linvoseltamab [INN]
Source URL:
Class:
PROTEIN
Status:
Investigational
Source:
NCT03700294: Phase 1 Interventional Terminated Advanced Solid Tumors
(2018)
Source URL:
Class:
PROTEIN
Status:
Investigational
Source:
NCT02665065: Phase 3 Interventional Active, not recruiting Acute Myeloid Leukemia
(2016)
Source URL:
Class:
PROTEIN
Status:
Investigational
Source:
INN:farletuzumab ecteribulin [INN]
Source URL:
Class:
PROTEIN
Status:
Investigational
Source:
NCT03633396: Phase 2 Interventional Completed Palmoplantar Pustulosis
(2019)
Source URL:
Class:
PROTEIN
Status:
Investigational
Source:
INN:boserolimab [INN]
Source URL:
Class:
PROTEIN
Status:
Investigational
Source:
INN:runimotamab [INN]
Source URL:
Class:
PROTEIN
Status:
Investigational
Source:
NCT03033524: Phase 2 Interventional Completed Recurrent Glioblastoma
(2016)
Source URL:
Class:
PROTEIN
Status:
Investigational
Source:
NCT03123055: Phase 1/Phase 2 Interventional Terminated Locally Advanced or Metastatic Urothelial Cell Carcinoma
(2017)
Source URL:
Class:
PROTEIN
